Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Adult Laboratory Classroom Study of the Efficacy and Safety of PRC-063 (Extended-Release Methylphenidate) for the Treatment of ADHD.
Ann ChildressAndrew J CutlerAndrea H MarraffinoSailaja BhaskarGraeme A E DonnellyPublished in: Journal of attention disorders (2021)
PRC-063 provided rapid and sustained symptom relief in adults with ADHD and was well tolerated. NCT03618030.
Keyphrases